H2020COFUND2020–2027

EuReCa · Institut Curie EuReCa PhD Programme

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2020-10-01 → 2027-03-31
EU contribution
€3,173,040
Participants
1
Scheme
MSCA-COFUND

Lines connect the coordinator with its partners.

Results in brief

Institut Curie EuReCa PhD Programme

In 2020, 2.7 million people in the EU were diagnosed with cancer and 1.3 million lost their lives to it. By 2035 cancer cases are estimated to increase by almost 25%, making it the leading cause of death in the EU. In addition, the overall economic impact of cancer in Europe is estimated to exceed €100 billion annually. The EU has been working on cancer for decades. The "Europe against cancer: action plan 1990-1994" contributed to major progress by supporting research and development financed by the EU budget. This plan was recently renewed by the "Europe's Beating Cancer Plan" 2021. In this context, the innovative COFUND programme in cancerology, EuReCa (Europe Research & Care), which benefits from the expansion of Institut Curie's unique bench-to-bedside approach, focuses on fostering interactions between basic and clinical research, and the industrial sector. The Institut Curie EuReCa PhD Programme has defined the following aims: • to train a new generation of early-stage researchers (ESRs) able to achieve excellence in basic sciences and their clinical and industrial applications in cancerology, • to implement innovative actions for career support by exposing ESRs to its '3i' vision: international, intersectoral and interdisciplinary experience, • to consolidate its leadership within its wide network of public and private partners, in order to facilitate the exchange of best practices in innovative doctoral training, as well as a structured and effective training program to successfully enter the increasingly competitive labour market. A total of 32 ESRs, 17 women and 15 men from 18 different countries have been recruited under 4 calls (2020, 2021, 2022, 2023), representing 3% of 1,058 applicants from 79 countries. Fellows completed a diversity of 117 training courses, participated in 155 conferences, and implemented 91 out-of-the-lab professional activities. They produced 18 scientific publications (all Open Access), 27 collaborations with academic and industrial partners, and 1 patent was filed. 16 fellows successfully obtained their PhD.

Data: CORDIS, © European Union

Project objective

Institut Curie proposes an innovative COFUND programme, EuReCa (Europe Research & Care) with the following aims: (1) to train a new generation of early-stage researchers (ESRs) able to achieve excellence in basic sciences and their clinical and industrial applications in cancerology; (2) to implement innovative actions for career support exposing ESRs to our 3i vision: international, intersectoral and interdisciplinary experience; (3) to consolidate its leadership within its wide network of public and private partners, facilitating exchange of best practices in innovative doctoral training, providing a structured and effective training program to prepare ESRs to successfully enter the increasingly competitive labour market.Institut Curie is a leading Excellence Cancer Centre bringing together an internationally-renowned interdisciplinary Research Centre and Hospital Group. This proposal will benefit in particular from the expansion of Institut Curies unique bench-to-bedside approach which brings together new research teams synergizing the expertise of basic scientists and physicians. The strong focus of this proposal on fostering interactions between basic and clinical research as well as the industrial sector will create a new generation of scientists able to quickly transfer results from fundamental research to patient care. This will take the form of diagnostics, prognostics, predictive biomarkers and imaging tests, treatment strategies, new drugs, new radiotherapy techniques, and public health initiatives on prevention and screening.At Institut Curie, the ambitious ESRs fellows of the EuReCa programme will be involved in the three pillars of the fight against cancer: Cutting-Edge Research, Advanced Healthcare, Information & Data Management. EuReCa aims to build a multi-faceted community able to communicate, interact, build and share expertise to tackle the challenges of cancer, ultimately leading to better health outcomes and fewer deaths due to cancer.

Original text from CORDIS.

Participants

  • INSTITUT CURIE · ParisCoordinatorFrance

Links

Data: CORDIS, © European Union